510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

Hospira Primary Sets

K142367510(k) TraditionalCleared Nov 25, 201492-day reviewClass II21 CFR 880.5440Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hospira, Inc. · FPA Set, Administration, Intravascular

Cleared on Nov 25, 2014 as substantially equivalent to K113683 (Hospira, Inc., 2012) and 1 other predicate after a 92-day review. Its family tree reaches back 4 generations to 2003. 1 of the 14 devices in its family, counting itself, has a Class I recall. 4 later devices descend from it. It has been recalled once.

Decided
Nov 25, 2014
Review
92 days
Class
Class II
Product code
FPA
Recalls
1
Predicates
2

Its longest line of descent runs back 4 generations to K030467 (2003). 9 ancestors in all, the oldest K780880 (1978). 4 later devices descend from it, 2 citing it directly. 1 of the 14 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2003: 1 other ancestor1994: 1 other ancestor1978: 1 other ancestor1991: 1 other ancestor2015: 1 descendant cleared2016: 1 descendant cleared2017: 1 descendant cleared2020: 1 descendant clearedK030467 · Gravitech TM Flow Controller Primary Set/Gravitech Flow Controller Extension Set · Iv Medical, Inc. · 2003K063239 · Lifeshield Latex-Free Gravitech Flow Controller I.V. Sets, Models 17528, 17527, 17525 & 17526 · Hospira, Inc. · 2006 · recalledK101677 · Hospira Infusion Blood Sets · Hospira, Inc. · 2010 · Class I recallK113683 · Lifeshield Vision Infusion Set with Pre-Pierced Reseal · Hospira, Inc. · 201219801990200020102020
  1. Root · 4 generations backK030467 Gravitech TM Flow Controller Primary Set/Gravitech Flow Controller…Iv Medical, Inc. · 2003
  2. 3 generations backK063239 Lifeshield Latex-Free Gravitech Flow Controller I.V. Sets, Models…Hospira, Inc. · 2006 · Recalled
  3. 2 generations backK101677 Hospira Infusion Blood SetsHospira, Inc. · 2010 · Recalled (Class I)
  4. 1 generation backK113683 Lifeshield Vision Infusion Set with Pre-Pierced ResealHospira, Inc. · 2012
  5. This deviceK142367 Hospira Primary SetsHospira, Inc. · 2014
  6. Descendant · cites it directly · 3 of its ownK143015 Hospira Primary SetsHospira, Inc. · 2015
  7. Descendant · cites it directly · 1 of its ownK160870 Hospira Administration SetsHospira, Inc. · 2016
  8. Descendant · 2 generations on · 0 of its ownK192375 Intellifuse Administration and Intellifuse Blood Administration SetsSmiths Medical Asd, Inc. · 2020
  9. Descendant · 2 generations on · 0 of its ownK161036 Hospira Extension Set, Hospira Primary SetHospira, Inc. · 2017

Class I recalls in this family

Most influential descendants

Showing 4 of 4 · See all
  • K143015Hospira Primary SetsHospira, Inc. · 2015 · cites it directly3descendants
  • K160870Hospira Administration SetsHospira, Inc. · 2016 · cites it directly1descendant
  • K192375Intellifuse Administration and Intellifuse Blood Administration SetsSmiths Medical Asd, Inc. · 2020 · 2 generations on0descendants
  • K161036Hospira Extension Set, Hospira Primary SetHospira, Inc. · 2017 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K030467Gravitech TM Flow Controller Primary Set/Gravitech Flow Controller Extension SetIv Medical, Inc.2003—
−3K063239Lifeshield Latex-Free Gravitech Flow Controller I.V. Sets, Models 17528…Hospira, Inc.20067
−2K101677Hospira Infusion Blood SetsHospira, Inc.2010Class I
−1K113683Lifeshield Vision Infusion Set with Pre-Pierced ResealHospira, Inc.2012—
0 (this device)K142367Hospira Primary SetsHospira, Inc.2014—
+1K143015Hospira Primary SetsHospira, Inc.2015—
+1K160870Hospira Administration SetsHospira, Inc.2016—
+2K192375Intellifuse Administration and Intellifuse Blood Administration SetsSmiths Medical Asd, Inc.2020—
+2K161036Hospira Extension Set, Hospira Primary SetHospira, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
197810
199110
199410
200310
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
201610
201710
202010
FIG. 1 — Lineage of K142367, 2003–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113683Lifeshield Vision Infusion Set with Pre-Pierced Reseal
Summary page 4
…Product Code(s) FPA Legally marketed device(s) to Hospira Primary sets: which equivalence is claimed LifeShield Vision Infusion Sets – K113683 Hospira Infusion Blood Sets – K101677 Reason for 510(k) submission The changes address…
Hospira, Inc.2012—
*K101677Hospira Infusion Blood Sets
Summary page 4
…Hospira Primary sets: which equivalence is claimed LifeShield Vision Infusion Sets – K113683 Hospira Infusion Blood Sets – K101677 Reason for 510(k) submission The changes addressed in this submission include: • Mod…
Hospira, Inc.2010Class I

Also cleared against K113683: 4 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K143015Hospira Primary SetsHospira, Inc.20153
K160870Hospira Administration SetsHospira, Inc.20161

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 12, 2026Class IIZ-3160-2026Process controlIntravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall. The presence of discoloration…

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K101677Hospira Infusion Blood SetsHospira, Inc. · 2010 · Direct predicate · ◆ on the line of descent in FIG. 18 Class I recalls

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 3.7 years on median.
  • 7 of the 9 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K143015 (Hospira, Inc., 2015) has gone furthest, with 3 descendants of its own.
  • 4 other devices also cite its predicate K113683.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

Hospira Primary sets are indicated for the delivery of fluids from a container to a patient’s vascular system.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K142367: Hospira Primary Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142367

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026